| Neutrophil contribution to spinal cord injury and repair V Neirinckx, C Coste, R Franzen, A Gothot, B Rogister, S Wislet Journal of neuroinflammation 11, 1-9, 2014 | 162 | 2014 |
| Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play V Neirinckx, C Coste, B Rogister, S Wislet-Gendebien Stem cells translational medicine 2 (4), 284-296, 2013 | 117 | 2013 |
| Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology A Golebiewska, AC Hau, A Oudin, D Stieber, YA Yabo, V Baus, ... Acta Neuropathologica 140, 919-949, 2020 | 103 | 2020 |
| Medication‐related osteonecrosis of the jaw: new insights into molecular mechanisms and cellular therapeutic approaches T Lombard, V Neirinckx, B Rogister, Y Gilon, S Wislet Stem cells international 2016 (1), 8768162, 2016 | 100 | 2016 |
| Concise review: Spinal cord injuries: how could adult mesenchymal and neural crest stem cells take up the challenge? V Neirinckx, D Cantinieaux, C Coste, B Rogister, R Franzen, ... Stem cells 32 (4), 829-843, 2014 | 89 | 2014 |
| RETRACTED ARTICLE: Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences S Wislet-Gendebien, E Laudet, V Neirinckx, P Alix, P Leprince, A Glejzer, ... Cellular and Molecular Life Sciences 69, 2593-2608, 2012 | 82 | 2012 |
| Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury V Neirinckx, G Agirman, C Coste, A Marquet, V Dion, B Rogister, ... Stem Cell Research & Therapy 6, 1-15, 2015 | 77 | 2015 |
| Adult bone marrow: which stem cells for cellular therapy protocols in neurodegenerative disorders? S Wislet-Gendebien, E Laudet, V Neirinckx, B Rogister BioMed Research International 2012 (1), 601560, 2012 | 62 | 2012 |
| Human bone marrow harbors cells with neural crest-associated characteristics like human adipose and dermis tissues C Coste, V Neirinckx, A Sharma, G Agirman, B Rogister, J Foguenne, ... PLoS One 12 (7), e0177962, 2017 | 37 | 2017 |
| AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion A Schuster, E Klein, V Neirinckx, AM Knudsen, C Fabian, AC Hau, ... Nature communications 11 (1), 6366, 2020 | 36 | 2020 |
| Adult bone marrow neural crest stem cells and mesenchymal stem cells are not able to replace lost neurons in acute MPTP-lesioned mice V Neirinckx, A Marquet, C Coste, B Rogister, S Wislet-Gendebien PLoS One 8 (5), e64723, 2013 | 33 | 2013 |
| In Vivo Tumorigenesis Was Observed after Injection of In Vitro Expanded Neural Crest Stem Cells Isolated from Adult Bone Marrow S Wislet-Gendebien, C Poulet, V Neirinckx, B Hennuy, JT Swingland, ... PLoS One 7 (10), e46425, 2012 | 32 | 2012 |
| Harnessing LRIG1-mediated inhibition of receptor tyrosine kinases for cancer therapy V Neirinckx, H Hedman, SP Niclou Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (1), 109-116, 2017 | 22 | 2017 |
| A composite sketch of fast-spiking parvalbumin-positive neurons O Bartholome, O de la Brassinne Bonardeaux, V Neirinckx, B Rogister Cerebral Cortex Communications 1 (1), tgaa026, 2020 | 20 | 2020 |
| Glioma stem cells in pediatric high-grade gliomas: from current knowledge to future perspectives MA Da-Veiga, B Rogister, A Lombard, V Neirinckx, C Piette Cancers 14 (9), 2296, 2022 | 19 | 2022 |
| Are neural crest stem cells the missing link between hematopoietic and neurogenic niches? C Coste, V Neirinckx, A Gothot, S Wislet, B Rogister Frontiers in Cellular Neuroscience 9, 218, 2015 | 18 | 2015 |
| Development and validation of a new mouse model to investigate the role of SV2A in epilepsy C Menten-Dedoyart, ME Serrano Navacerrada, O Bartholome, ... PLoS One 11 (11), e0166525, 2016 | 15 | 2016 |
| Neural fate of mesenchymal stem cells and neural crest stem cells: which ways to get neurons for cell therapy purpose V Neirinckx, C Coste, B Rogister, S Wislet-Gendebien Trends in cell signaling pathways in neuronal fate decision, 327-358, 2013 | 15 | 2013 |
| Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle JS Gil, M Dubois, V Neirinckx, A Lombard, N Coppieters, P D’Arrigo, D Isci, ... Molecular Therapy-Oncolytics 26, 35-48, 2022 | 11 | 2022 |
| Patient-oriented perspective on chemokine receptor expression and function in glioma D Isci, G D’Uonnolo, M Wantz, B Rogister, A Lombard, A Chevigné, ... Cancers 14 (1), 130, 2021 | 9 | 2021 |
